Your browser doesn't support javascript.
loading
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol.
Mittelman, Moshe; Filanovsky, Kalman; Ofran, Yishai; Rosenbaum, Hanna; Raanani, Pia; Braester, Andrei; Goldschmidt, Neta; Kirgner, Ilya; Herishanu, Yair; Perri, Chava; Ellis, Martin; Oster, Howard S.
Affiliation
  • Mittelman M; Department of Medicine A, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv, 64239, Israel. moshemt@tlvmc.gov.il.
  • Filanovsky K; Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel. moshemt@tlvmc.gov.il.
  • Ofran Y; Kaplan Medical Center, Rehovot, Israel.
  • Rosenbaum H; Hebrew University, Jerusalem, Israel.
  • Raanani P; Rambam Medical Center, Haifa, Israel.
  • Braester A; Technion, Haifa, Israel.
  • Goldschmidt N; Rambam Medical Center, Haifa, Israel.
  • Kirgner I; Technion, Haifa, Israel.
  • Herishanu Y; Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel.
  • Perri C; Rabin Medical Center, Petah Tikva, Israel.
  • Ellis M; Western Galilee Medical Center, Nahariya, Israel.
  • Oster HS; Bar-Ilan University, Safed, Israel.
Ann Hematol ; 95(11): 1811-8, 2016 Oct.
Article in En | MEDLINE | ID: mdl-27546027
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Thalidomide / Myelodysplastic Syndromes / Angiogenesis Inhibitors / Antimetabolites Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2016 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Thalidomide / Myelodysplastic Syndromes / Angiogenesis Inhibitors / Antimetabolites Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2016 Document type: Article Affiliation country: Country of publication: